Factor 1: Importance of Research
Consolidates: Significance & Innovation
2
1 (Exceptional)
3 (High)
5 (Medium)
7 (Low)
9 (Poor)
Factor 2: Rigor and Feasibility
Consolidates: Approach, Experimental Design, Feasibility & Power
2
1 (Exceptional)
3 (High)
5 (Medium)
7 (Low)
9 (Poor)
Factor 3: Expertise and Resources
Consolidates: Investigator & Environment (Binary unweighted evaluation)
Investigator Team & Institutional Environment suitability:
Inter-Reviewer Deliberation Variance:
Low (±0.3)
Simulated 3-reviewer score span before consensus agreement:
R1: 2.0 | R2: 2.3 | R3: 2.3
NIH Framework Overhaul Comparison
Policy Architecture
| Simplified 3-Factor (New) | Scoring Mode | Traditional 5-Criterion (Legacy) | Scrutiny Shift |
|---|---|---|---|
| Factor 1: Importance | 1-9 Numeric | Significance & Innovation | Focuses on transformative potential rather than novelty buzzwords |
| Factor 2: Rigor & Feasibility | 1-9 Numeric | Approach | Deep scrutiny of sample power, blinding, transparency, & robust plans |
| Factor 3: Expertise & Resources | Appropriate / Concerns | Investigator & Environment (1-9) | Eliminates pedigree & institutional prestige bias in numeric scores |
Deliberation Outcome & Fundability
NIH 10–90 Scale
Overall Impact Score
22
Exceptional / High
Study Section Percentile
14.5%
Within 15% Payline
Triage Deliberation
Discussed
Top 50% Scored
Study Section Proposal Distribution (n=40)
Payline Cutoff: 15th Percentile
Current Proposal
Funded Cohort (≤ 15%)
Discussed / Not Funded
Triaged (Bottom 50%)
Review Committee Deliberation Profile
Structured Feedback
Factor 1 Contribution:
Strong scientific rationale with high potential for disease impact.
Factor 2 Contribution:
Exceptional rigor, validated controls, and transparent statistical methodology.
Factor 3 Assessment:
Unconditional approval. Team possesses required epigenetic editing and animal model expertise.
Generated Review Summary